Accreditation - Diagnosing and Treating Opioid and Other Substance Use Disorders

Available May 26, 2024 - May 25, 2026
Jointly provided by Partners for Advancing Clinical Education (PACE) and Hospital Medicine Seminars, LLC
Target Audience
This activity is intended for DEA-registered practitioners, with the exception of practitioners that are solely veterinarians, including but not limited to physicians, nurse practitioners, physician assistants and dentists who treat and manage patients with opioid or other substance use disorders.
Educational Objectives
Upon completion of this activity, participants should be able to:
  • Discuss updates and new evidence in the medical literature regarding substance use disorders
  • List recent guideline updates and recommendations regarding substance use disorders
  • Identify best practices for treatment of opioid use disorder
  • Discuss interprofessional team-based interventions that may improve patient outcomes
Instructions for Credit
Participation in this self-study activity should be completed in 8.0 hour(s). To

successfully complete this activity and receive CE credit, learners must follow these steps during the period from May 26, 2024 through May 25, 2026:

For claiming AMA PRA Category 1 Credit™, ANCC, ACPE, and IPCE contact
1. Review the objectives and disclosures
2. Study the educational content
3. Visit registration page
4. Create a login
5. Complete the activity evaluation
Upon completion of all evaluation questions your credit will be made available for
download immediately.

For Pharmacists: Upon successfully completing the online evaluation, your credit will be submitted to CPE Monitor.  Please check your NABP account within thirty (30) days to make sure the credit has posted.

For claiming ABIM MOC/AMA PRA Category 1 Credit™:
1. Review the objectives and disclosures
2. Study the educational content
3. Visit registration page
4. Create a login
5. Successfully complete activity post-test with a passing grade of at least 75%
6. Complete the activity evaluation
Upon completion of all evaluation questions your credit will be made available for
download immediately.


Steve Burgess, MD, MBA
Cheyenne Regional Medical Center

Jason Ackerman, MD
Addiction and Internal Medicine Clinic, Sheridan, WY             


PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

  • Steve Burgess, MD, MBA has no relevant financial relationships.
  • Jason Ackerman, MD, has no relevant financial relationships.

    Joint Accreditation Statement

    In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Hospital Medicine Seminars, LLC.  PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physician Continuing Education

    PACE designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Board of Internal Medicine Maintenance of Certification

       Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    To receive CME credit and/or MOC points, you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PACE’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving PACE permission to use this information/data to report your participation to these Boards JA-PARS.

    Nursing Continuing Professional Development
    The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 8.0 contact hours. 
    Designated for 3.3 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses. 

    Pharmacy Continuing Education
    PACE designates this continuing education activity for 8.0 contact hour(s) (0.8 CEUs) of the Accreditation Council for Pharmacy Education.
    (Universal Activity Number - JA4008073-9999-24-112-H08-P)
    Type of Activity: Application

    Hardware/Software Requirements

    • A laptop or desktop computer, or mobile device
    • Internet access
    • Updated internet browser
    • NOTE: some employers block access to online video content, so if you cannot access from work, please try accessing on your cell phone or from home.

    Policy on Privacy and Confidentiality
    Please see final activity for the policy on privacy and confidentiality that relates to this internet activity. 

     Interprofessional Continuing Education

    This activity was planned by and for the healthcare team, and learners will receive 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

     Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    PACE Contact Information
    For additional information about the accreditation of this activity, please visit